Results 251 to 260 of about 1,318,825 (382)

Donor procurement for intestinal transplantation [PDF]

open access: yes, 1997
Abu-Elmagd, K   +5 more
core  

Pancreas Transplantation With Enteroanastomosis to Native Duodenum Poses Technical Challenges—But Offers Improved Endoscopic Access for Scheduled Biopsies and Therapeutic Interventions

open access: yesAmerican Journal of Transplantation, 2015
R. Horneland   +10 more
semanticscholar   +1 more source

Tumor‐infiltrating B cells participate in shaping the immunosuppressive microenvironment in solid tumors

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Tumor‐infiltrating B cells (TIBs) exhibit dual roles in the tumor microenvironment (TME) of solid tumors. While they can enhance anti‐tumor immunity through antibody production and immune activation, certain subsets—such as regulatory B cells (Bregs) and immunosuppressive plasma cells—contribute to immune evasion by secreting inhibitory ...
Zhitong Li   +5 more
wiley   +1 more source

Belatacept in Pancreas Transplantation: Promising Insights From a Cohort Series. [PDF]

open access: yesTranspl Int
Masset C   +10 more
europepmc   +1 more source

Enteric-drained pancreas transplants monitored by fine-needle aspiration biopsy [PDF]

open access: yes, 1997
A. Sugitani   +16 more
core   +2 more sources

Kidney and Pancreas Transplantation in the United States, 1998–2007: Access for Patients with Diabetes and End-Stage Renal Disease [PDF]

open access: hybrid, 2009
Keith McCullough   +5 more
openalex   +1 more source

The impact of race on metabolic, graft, and patient outcomes after pancreas transplantation

open access: green, 2021
Haley M. Gonzales   +6 more
openalex   +2 more sources

Novel therapeutic strategy targeting STMN1 using chlorambucil‐conjugated pyrrole–imidazole polyamide in small cell lung cancer

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Small cell lung cancer (SCLC) is aggressive and difficult to treat but exhibits high levels of stathmin 1 (STMN1), a candidate therapeutic target. In this study, the authors synthesized a chlorambucil (Chb)‐conjugated pyrrole–imidazole polyamide (PIP) compound targeting the STMN1 promoter and DNA sequences and evaluated its efficacy in ...
Ryohei Yoshikawa   +23 more
wiley   +1 more source

Head‐to‐head comparison of TKI and CPI first‐line treatment strategies in advanced renal cell carcinoma—Real‐world data from the German research platform CARAT

open access: yesInternational Journal of Cancer, EarlyView.
What's New? The current standard of care for locally advanced or metastatic renal cell carcinoma (aRCC) is either a combination of two immune checkpoint inhibitors (CPI) or a CPI plus a tyrosine kinase inhibitor (TKI). Here, the authors simulate a head‐to‐head trial comparing the real‐world effectiveness of these combination therapies with TKI ...
Peter J. Goebell   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy